SCHEMBL2079488

SCHEMBL2079488

COc1ccc(N(c2ccc(C=CC#N)cc2)c2ccc(OC)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.59
CYP3A4 P08684 3/20 0.47
TSHR P16473 2/20 0.47
ALDH1A1 P00352 2/20 0.47
LMNA P02545 2/20 0.47
TP53 P04637 1/20 0.47
TRPA1 O75762 1/20 0.46
RELA Q04206 1/20 0.46
CYP1A2 P05177 4/20 0.45
HPGD P15428 2/20 0.45
MAPT P10636 2/20 0.45
NFKB1 P19838 1/20 0.45
APEX1 P27695 1/20 0.45
BLM P54132 1/20 0.45
PMP22 Q01453 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
CYP1A1 P04798 3/20 0.44
CYP1B1 Q16678 3/20 0.44
ESR1 P03372 2/20 0.44
PTGS2 P35354 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12845183 1.00 KDM4E (0.59) KDM4ECYP3A4TSHRALDH1A1LMNA
SCHEMBL12780456 0.94 RELA (0.57) KDM4ECYP3A4TSHRALDH1A1LMNA
SCHEMBL442274 0.89 KDM4E (0.57) KDM4ECYP3A4TSHRALDH1A1LMNA
SCHEMBL442275 0.89 KDM4E (0.57) KDM4ECYP3A4TSHRALDH1A1LMNA
SCHEMBL4403050 0.84 RELA (0.63) KDM4ECYP3A4TSHRALDH1A1LMNA
SCHEMBL5490866 0.84 RELA (0.63) KDM4ECYP3A4TSHRALDH1A1LMNA
SCHEMBL8944100 0.84 RELA (0.63) KDM4ECYP3A4TSHRALDH1A1LMNA
SCHEMBL5491168 0.84 RELA (0.63) KDM4ECYP3A4TSHRALDH1A1LMNA
SCHEMBL21738407 0.84 RELA (0.63) KDM4ECYP3A4TSHRALDH1A1LMNA
SCHEMBL8944105 0.84 RELA (0.63) KDM4ECYP3A4TSHRALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140034623-A1 SWITCHABLE SPECIAL EFFECT SUBSTANCES BASF SE (DE) 2014-02-06 US disclosed
US-8586745-B2 Switchable special effect substances BASF SE (DE) 2013-11-19 US disclosed
US-20110060113-A1 SWITCHABLE SPECIAL EFFECT SUBSTANCES BASF SE (DE) 2011-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110060113-A1 SWITCHABLE SPECIAL EFFECT SUBSTANCES PPARG, PTGER4, NR2E3 KDM4E 3047/4885CYP3A4 63/4885TSHR 1489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.